Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study.
Cowan
J D
JD
Green
S
S
Lucas
J
J
Weick
J K
JK
Balcerzak
S P
SP
Rivkin
S E
SE
Coltman
C A
CA
Baker
L H
LH
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged; D015206:Southwestern United States; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
D014747:Vinblastine